Ryuhei Tanaka
Hidaka, 3501298, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Systematic review of antiemetic therapy for low emetogenic chemotherapy: comparing 5-HT3 receptor antagonists and dexamethasone.
Journal: International journal of clinical oncology
Published: April 12, 2026
Ultrasonographic Monitoring of Cytomegalovirus Gastroenteritis After Hematopoietic Stem Cell Transplantation: A Case Report.
Journal: Pediatric blood & cancer
Published: February 10, 2026
Infantile Ganglioneuroblastoma Causing Growth Failure and Hypertensive Cardiomyopathy From Excessive Catecholamine Production.
Journal: Journal of pediatric hematology/oncology
Published: April 27, 2025
Clinical benefits of adding olanzapine to 5-HT3 receptor antagonist, NK1 receptor antagonist, and dexamethasone for the prevention of nausea and vomiting in highly emetogenic chemotherapy: a systematic review and meta-analysis of the Clinical Practice Guidelines for Antiemesis 2023 from the Japan Society of Clinical Oncology.
Journal: International journal of clinical oncology
Published: September 25, 2024
Efficacy and safety of dexamethasone sparing for the prevention of nausea and vomiting associated with moderately emetogenic chemotherapy: a systematic review and meta-analysis of Clinical Practice Guidelines for Antiemesis 2023 from Japan Society of Clinical Oncology.
Journal: International journal of clinical oncology
Published: August 01, 2024
Efficacy and safety of multi-day antiemetic treatment for patients undergoing multi-day chemotherapy: a systematic review of Clinical Practice Guidelines for Antiemesis 2023 from Japan Society of Clinical Oncology.
Journal: International journal of clinical oncology
Published: July 26, 2024
Efficacy and safety of dexamethasone sparing for the prevention of nausea and vomiting associated with highly emetogenic risk antineoplastic agents: a systematic review and meta-analysis of the Clinical Practice Guidelines for Antiemesis 2023 from the Japan Society of Clinical Oncology.
Journal: International journal of clinical oncology
Published: July 17, 2024
Defining the clinical benefits of adding a neurokinin-1 receptor antagonist to control chemotherapy-induced nausea and vomiting in moderately emetogenic chemotherapy: a systematic review and meta-analysis of the clinical practice guidelines for antiemesis 2023 from the Japan society of clinical oncology.
Journal: International journal of clinical oncology
Published: July 11, 2024
Catheter-related bloodstream infection by a newly proposed "Mycobacterium toneyamachuris" in a boy with B-cell precursor acute lymphoblastic leukemia.
Journal: Diagnostic microbiology and infectious disease
Published: July 02, 2024
Non-pharmacological treatments for anticipatory nausea and vomiting during chemotherapy: a systematic review and meta-analysis of the Clinical Practice Guidelines for Antiemesis 2023.
Journal: International journal of clinical oncology
Published: March 25, 2024
2023 Japan Society of clinical oncology clinical practice guidelines update for antiemesis.
Journal: International journal of clinical oncology
Published: February 27, 2024
Rare Case of BCOR::CCNB3 Sarcoma of Bone.
Journal: The American journal of case reports
Published: March 14, 2023
Last Updated: 09/26/2026